Fresh article on CAP in todays Lancet!
Community-acquired pneumonia causes great mortality and morbidity and
high costs worldwide. Empirical selection of antibiotic treatment is the
cornerstone of management of patients with pneumonia. To reduce the
misuse of antibiotics, antibiotic resistance, and side-effects, an
empirical, effective, and individualised antibiotic treatment is needed.
Follow-up after the start of antibiotic treatment is also important,
and management should include early shifts to oral antibiotics,
stewardship according to the microbiological results, and short-duration
antibiotic treatment that accounts for the clinical stability criteria.
New approaches for fast clinical (lung ultrasound) and microbiological
(molecular biology) diagnoses are promising. Community-acquired
pneumonia is associated with early and late mortality and increased
rates of cardiovascular events. Studies are needed that focus on the
long-term management of pneumonia.
Full text:
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2960733-4/abstract
No comments:
Post a Comment